Physician profile
Gabriela Mroueh
NPI 1548657661
$17,842.98
in general payments reported to CMS, 2019-2025
55 companies · $3,846 in 2025
The $3,846 reported for 2025 was more than what 85% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $1,055 · 2021: $2,657 · 2022: $2,502 · 2023: $3,487 · 2024: $4,073 · 2025: $3,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $1,121 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,235.32 |
| Travel and Lodging | $1,121.06 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,243.55 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $2,033.22 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Medtronic, INC. | $1,433.42 | 2021-2025 | Minimed 780g, Inceptiv, Vanta Adaptivestim |
| Lilly USA, LLC | $1,230.31 | 2020-2025 | Jardiance, Mounjaro, Baqsimi |
| Dexcom, INC. | $1,126.69 | 2020-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $947.51 | 2020-2023 | Farxiga |
| Amgen INC. | $897.21 | 2020-2025 | Repatha, Evenity, Prolia |
| Mannkind Corporation | $850.52 | 2020-2025 | Afrezza |
| Corcept Therapeutics | $671.40 | 2021-2025 | Korlym |
| Cequr Corporation | $488.96 | 2022-2025 | Cequr Simplicity |
| Abbvie INC. | $471.84 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $458.55 | 2021-2025 | Jardiance, Synjardy |
| Xeris Pharmaceuticals, INC. | $455.31 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Ascensia Diabetes Care US INC. | $412.80 | 2023-2025 | |
| Intuity Medical INC | $401.97 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriela Mroueh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.